Literature DB >> 18200002

Aminoacidurias: Clinical and molecular aspects.

S M R Camargo1, D Bockenhauer, R Kleta.   

Abstract

Inherited aminoacidurias are caused by defective amino-acid transport through renal (reabsorption) and in many cases also small intestinal epithelia (absorption). Recently, many of the genes causing this abnormal transport have been molecularly identified. In this review, we summarize the latest findings in the clinical and molecular aspects concerning the principal aminoacidurias, cystinuria, lysinuric protein intolerance, Hartnup disorder, iminoglycinuria, and dicarboxylic aminoaciduria. Signs, symptoms, diagnosis, treatment, causative or candidate genes, functional characterization of the encoded transporters, and animal models are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18200002     DOI: 10.1038/sj.ki.5002790

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Lysine triggers apoptosis through a NADPH oxidase-dependent mechanism in human renal tubular cells.

Authors:  Daniela Verzola; Annamaria Famà; Barbara Villaggio; Maia Di Rocco; Alchiede Simonato; Elena D'Amato; Fabio Gianiorio; Giacomo Garibotto
Journal:  J Inherit Metab Dis       Date:  2012-03-09       Impact factor: 4.982

Review 2.  Cystinuria: mechanisms and management.

Authors:  Donna J Claes; Elizabeth Jackson
Journal:  Pediatr Nephrol       Date:  2012-01-27       Impact factor: 3.714

Review 3.  Laboratory diagnostic approaches in metabolic disorders.

Authors:  Ruben Bonilla Guerrero; Denise Salazar; Pranoot Tanpaiboon
Journal:  Ann Transl Med       Date:  2018-12

4.  Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria.

Authors:  Charles G Bailey; Renae M Ryan; Annora D Thoeng; Cynthia Ng; Kara King; Jessica M Vanslambrouck; Christiane Auray-Blais; Robert J Vandenberg; Stefan Bröer; John E J Rasko
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

Review 5.  Garrod's Croonian Lectures (1908) and the charter 'Inborn Errors of Metabolism': albinism, alkaptonuria, cystinuria, and pentosuria at age 100 in 2008.

Authors:  Charles R Scriver
Journal:  J Inherit Metab Dis       Date:  2008-10-12       Impact factor: 4.982

6.  Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters.

Authors:  Stefan Bröer; Charles G Bailey; Sonja Kowalczuk; Cynthia Ng; Jessica M Vanslambrouck; Helen Rodgers; Christiane Auray-Blais; Juleen A Cavanaugh; Angelika Bröer; John E J Rasko
Journal:  J Clin Invest       Date:  2008-11-06       Impact factor: 14.808

7.  Renal Involvement in a French Paediatric Cohort of Patients with Lysinuric Protein Intolerance.

Authors:  C Nicolas; N Bednarek; V Vuiblet; O Boyer; A Brassier; P De Lonlay; L Galmiche; P Krug; V Baudouin; S Pichard; M Schiff; C Pietrement
Journal:  JIMD Rep       Date:  2015-11-26

8.  Quantifying the relative contributions of different solute carriers to aggregate substrate transport.

Authors:  Mehdi Taslimifar; Lalita Oparija; Francois Verrey; Vartan Kurtcuoglu; Ufuk Olgac; Victoria Makrides
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

9.  mTOR Regulates Endocytosis and Nutrient Transport in Proximal Tubular Cells.

Authors:  Florian Grahammer; Suresh K Ramakrishnan; Markus M Rinschen; Alexey A Larionov; Maryam Syed; Hazim Khatib; Malte Roerden; Jörn Oliver Sass; Martin Helmstaedter; Dorothea Osenberg; Lucas Kühne; Oliver Kretz; Nicola Wanner; Francois Jouret; Thomas Benzing; Ferruh Artunc; Tobias B Huber; Franziska Theilig
Journal:  J Am Soc Nephrol       Date:  2016-06-13       Impact factor: 10.121

10.  Accurate discrimination of Hartnup disorder from other aminoacidurias using a diagnostic ratio.

Authors:  H A Haijes; Hubertus C M T Prinsen; Monique G M de Sain-van der Velden; Nanda M Verhoeven-Duif; Peter M van Hasselt; Judith J M Jans
Journal:  Mol Genet Metab Rep       Date:  2019-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.